Publications

SELECTED
PUBLICATIONS

2022

Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase.

Onyenaka C, Idowu KA, Ha NP, Graviss EA, Olaleye OA.  Int J Mol Sci. 2023 Dec 5;24(24):17142. doi:10.3390/ijms242417142. PMID: 38138972; PMCID: PMC10742973

A Computational Evaluation of Structural Stability of Omicron and Delta mutations of SARS CoV-2 Spike Protein and hACE2 Interactions. Informatics in Medicine-unlocked.

Kehinde A. Idowu, Collins Onyenaka, and Omonike A. Olaleye (2022).https://doi.org/10.1016/j.imu.2022.101074.

Inhibitory Mechanism of Ambroxol and Bromhexine Hydrochlorides as Potent Blockers of Molecular Interaction between SARS-CoV-2 Spike protein and Human Angiotensin-converting Enzyme-2

Idowu A. Kehinde, Anu Egbejimi, Manvir Kaur, Collins Onyenaka, Tolulope Adebusuyi, Omonike A. Olaleye. April 2022. Journal of Molecular Graphics and Modelling.108201. https://doi.org/10.1016/j.jmgm.2022.108201.

Inhibitory mechanism of Clioquinol and Its Derivatives at the Exopeptidase site of Human Angiotensin-Converting Enzyme-2 and Receptor Binding Domain of SARS-CoV-2 Viral Spike protein.
Idowu A. Kehinde, Anu Egbeyemi, Manvir Kaur, Collins Onyenaka, Tolulope Adebusuyi, Omonike A. Olaleye (2022). J. Biomol. Str. Dyn.